18/11/2025 - General information
Solidarity, through La Marató de 3Cat, continues to drive research. The 10 million euros raised in the latest edition, dedicated to respiratory diseases, will be used to fund 36 research projects from sixty research groups. Among them are two projects led by researchers from the Hospital del Mar Research Institute and Hospital del Mar. One of the projects, led by Dr. Joan Ramon Masclans, head of the Intensive Care Medicine Service at Hospital del Mar and coordinator of the Critical Illness Research Group at the HMRIB, will focus on predicting treatment response in patients with acute hypoxemic respiratory failure treated with high-flow nasal cannula, using omics and clinical data. To do so, they will receive nearly 300,000 euros. The project also involves the Institute for Bioengineering of Catalonia (IBEC).
17/11/2025 - General information
Dr José Yélamos López has received the Carmen Delgado/Miguel Pérez Mateo Grant in the basic research category. The award ceremony for the grant, worth 100,000 euros, took place on 5 November. These grants are awarded by the Pancreatic Cancer Association, in collaboration with the Spanish Association of Pancreatology and the Spanish Association of Gastroenterology, with the aim of promoting basic and clinical research in pancreatic cancer. They are made possible thanks to the public's participation in the Carrera de las Ciudades contra el Cáncer de Páncreas (Cities Race Against Pancreatic Cancer), which in 2025 reached its tenth edition.
Més informació "Carmen Delgado/Miguel Pérez Mateo Grant for Dr José Yélamos López"
12/11/2025 - Institutional news
Dr. Xavier Nogués, Dr. Gloria Nohales, and Dr. Antoni Payà are three of the professionals who will receive, on December 1, one of the Professional Excellence Prizes awarded by the Col·legi de Metges de Barcelona. These distinctions acknowledge their career achievements and will be presented at a ceremony held at the Axa Auditorium in L'Illa Diagonal. The Professional Excellence Prizes of the Col·legi de Metges de Barcelona (COMB) are awarded to physicians in recognition of careers distinguished by commitment, honesty, altruism, integrity, and excellence. The awards are given in the fields of primary care medicine, hospital care medicine, medicine in other healthcare settings, biomedical research, medical education and training, and the humanities, cooperation, and management. The 2025 edition marks their 21st year.
11/11/2025 - General information
Dr. Anna Bigas, coordinator of the Stem Cells and Cancer Research Group at the Hospital del Mar Research Institute and the Josep Carreras Leukaemia Research Institute, has just joined the journal Development as an Associate Editor. The journal is published by The Company of Biologists, a non-profit organization led by leading scientists in the field. This is one of the reference publications in its area. Dr. Bigas will be responsible for evaluating and deciding on the publication of studies related to the development of hematopoietic stem cells and how their deregulation contributes to the onset of blood diseases.
Més informació "Dr. Anna Bigas begins a new chapter as Associate Editor of the journal Development"
06/11/2025 - Press release
A systematic review of published studies on service coverage for these conditions in adults, published in The Lancet Regional Health - Europe, reveals this gap. Overall, there is little information about the capacity to provide care for people with mental disorders across European countries. Existing data show great disparities between nations and generally low coverage for nearly all disorders. These figures put at risk the World Health Organization's goal of increasing coverage for these patients by 50% by 2030.
04/11/2025 - General information
The Pharmacokinetics and Pharmacodynamics (PK/PD) Research Team at Hospital del Mar has received a competitive international grant awarded by the pharmaceutical company Pfizer, as part of the "Independent Research Grant Program - Pharmacokinetics-pharmacodynamics (PK/PD) of Aztreonam-Avibactam (ATM-AVI) in Special Populations." The selected project, chosen among proposals from several European centers, aims to optimize the use of the new antibiotic aztreonam-avibactam in patients with renal impairment - a population particularly vulnerable to severe infections caused by multidrug-resistant bacteria. The project is led by Dr. Mila Montero and Dr. Sònia Luque.
Més informació "Pfizer International Grant for a Project at Hospital del Mar on Antibiotic Therapy"
31/10/2025 - Press release
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave differently in TRD compared with non-resistant patients. The study reports the first results of the PROMPT consortium, which aims to combine clinical and molecular data using machine learning to predict which patients are at risk of developing TRD.
Més informació "Treatment-resistant depression identified as a distinct molecular subtype"
30/10/2025 - Events
For a project in the field of genomics of chronic lymphocytic leukemia. The grant was awarded by the Spanish Group of Chronic Lymphocytic Leukemia and presented during the congress of the Spanish Society of Hematology and Hemotherapy.
29/10/2025 - Events
The two institutions are leading a joint Cell Therapy and Substances of Human Origin (SoHO) Programme, which aims to become a key player in the field of these new treatments in Catalonia. The Minister of Health, Olga Pané, the Director General of the Department of Research, Teresa Sanchís, and the Director General of the BST, Anna Millan, took part in the presentation of the programme. They also visited the new cell culture laboratory at the Hospital del Mar Research Institute and the Josep Carreras Leukaemia Research Institute, which will strengthen the cell therapy capabilities of both centres.
22/10/2025 - General information
The Hemodynamics Unit of the Cardiology Department at Hospital del Mar took part in a study published in the New England Journal of Medicine. The study demonstrates that one month after undergoing treatment for a myocardial infarction, patients can safely continue therapy with a single antiplatelet drug without added risk.
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
